Pacer Lunt MidCap Multi-Factor Alternator ETF
PAMC - ETF AI Analysis
Top Page
Pacer Lunt MidCap Multi-Factor Alternator ETF (PAMC)
PAMC, the Pacer Lunt MidCap Multi-Factor Alternator ETF, earns a solid overall rating largely because several of its key holdings combine strong financial performance with positive business outlooks. Standout positions like TechnipFMC, Exelixis, and Medpace Holdings support the fund’s quality through robust profitability, favorable earnings commentary, and generally positive technical trends, even though some show signs of being overbought or potentially overvalued. On the risk side, holdings such as Nutanix and Booz Allen introduce concerns around leverage, revenue growth challenges, and bearish technical signals, highlighting that investors should be mindful of volatility and valuation risks in this mid-cap, multi-factor strategy.
PAMC vs. SPDR S&P 500 ETF (SPY)
- AUM
- 49.31M
- Region
- North America
- Expense Ratio
- 0.60%
- Beta
- 0.80
- Issuer
- Pacer
- Inception Date
- Jun 24, 2020
- Dividend Yield
- 1.34%
- Asset Class
- Equity
- Index Tracked
- Lunt Capital U.S. MidCap Multi-Factor Rotation Index
PAMC Summary
PAMC is an exchange-traded fund that follows the Lunt Capital U.S. MidCap Multi-Factor Rotation Index, focusing on medium-sized U.S. companies. It mainly invests in sectors like technology, industrials, and health care, and holds well-known names such as Okta and Lattice Semiconductor. The fund uses a rules-based strategy that shifts between styles like value, momentum, and quality, aiming to balance growth potential with some stability and diversification across many mid-cap stocks. A key risk is that mid-cap stocks and the fund’s rotation strategy can go up and down with the market and may be more volatile than large, established companies.
How much will it cost me?
This ETF has an expense ratio of 0.60%, which means you’ll pay about $6 per year for every $1,000 invested. That’s higher than the average ETF because it uses an actively managed, multi-factor strategy rather than a simple passive index approach.
What would affect this ETF?
PAMC is heavily invested in U.S. mid-cap technology and industrial companies, so it could benefit if innovation, infrastructure spending, and economic growth stay strong, especially when investors favor growth and quality stocks. On the downside, higher interest rates, a slowdown in the U.S. economy, or sector-specific setbacks in tech or health care could hurt performance, and the fund’s rotation strategy may lag if market leadership changes very quickly.
PAMC Top 10 Holdings
PAMC is leaning hard into U.S. mid-cap tech, with names like Okta and Entegris helping to power the fund thanks to rising momentum and solid fundamentals. Rambus adds to that tech-heavy story with a generally positive outlook tied to AI, even if its trading has been a bit mixed lately. On the other side of the ledger, Lattice Semiconductor and MACOM have lost some steam in the short term, and Cytokinetics has been lagging as it works through financial and regulatory hurdles. Overall, performance is being driven by a concentrated cluster of mid-cap technology leaders.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Manhattan Associates | 3.33% | $1.64M | $15.03B | 46.21% | 75Outperform | |
| DocuSign | 2.71% | $1.33M | $14.98B | 15.57% | 71Outperform | |
| Booz Allen | 1.99% | $983.25K | $10.31B | 1.87% | 65Neutral | |
| Toast Inc | 1.93% | $951.12K | $19.81B | -12.57% | 73Outperform | |
| TechnipFMC | 1.97% | $970.58K | $25.43B | 51.29% | 80Outperform | |
| Exelixis | 1.88% | $925.39K | $17.25B | 60.22% | 78Outperform | |
| Medpace Holdings | 1.88% | $928.02K | $18.59B | 9.91% | 79Outperform | |
| Nutanix | 1.59% | $786.15K | $16.40B | -10.10% | 62Neutral | |
| Houlihan Lokey | 1.54% | $757.16K | $10.14B | -22.26% | 70Outperform | |
| Aecom | 1.61% | $795.37K | $9.04B | -47.17% | 71Outperform |
PAMC Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PAMC, the sentiment is Negative. The current price of 48.75 is below the 20-day moving average (MA) of 48.80, below the 50-day MA of 51.00, and below the 200-day MA of 51.83, indicating a bearish trend. The MACD of -0.56 indicates Negative momentum. The RSI at 44.97 is Neutral, neither overbought nor oversold. The STOCH value of 54.20 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PAMC.
PAMC Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $48.75 | $53.00(8.72% Upside) | $49.31M | 0.60% | 71Outperform | |
| $25.12 | $28.88(14.97% Upside) | $53.99M | 0.80% | 70Outperform | |
| $27.64 | $31.97(15.66% Upside) | $37.94M | 0.59% | 68Neutral | |
| $25.88 | $29.94(15.69% Upside) | $13.66M | 0.79% | 71Outperform | |
| $25.93 | $31.42(21.17% Upside) | $11.77M | 0.47% | 63Neutral | |
| $67.44 | $79.80(18.34% Upside) | $8.17M | 0.35% | 68Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| PAMC | Pacer Lunt MidCap Multi-Factor Alternator ETF | 48.75 | 5.40 | 12.45% | |
| KMID | Virtus KAR Mid-Cap ETF | 25.12 | 1.72 | 7.37% | |
| MMID | MFS Active Mid Cap ETF | 27.64 | 3.74 | 15.66% | |
| SMCP | SMART Mid Cap ETF | 25.88 | 1.01 | 4.07% | |
| TMID | T. Rowe Price Mid Cap Equity Research ETF | 25.93 | 0.68 | 2.70% | |
| MCDS | JPMorgan Fundamental Data Science Mid Core ETF | 67.44 | 11.75 | 21.10% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
